Method for increasing mean survival times of transplants with LFA-1-specific antibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 10, 2001
Grant Date -
N/A
app pub date -
Oct 30, 1995
filing date -
Jan 21, 1993
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Mean survival times of a functional transplant of solid organs in a patient are increased by administering to the patient an initial dosing of a therapeutically effective amounts of a monoclonal antibody directed against the human LFA-1 molecule in the two hours after grafting and then administering daily dosing during a period of approximately nine days.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully